BN Business News
Add your company to Business Communicator →

Regulation & law · 10/09/2015

NIH to Grant Exclusive License for Cardio-Metabolic Peptide Invention to Corvidia Corporation

The National Institutes of Health is considering granting a start-up exclusive option license to Corvidia Corporation for the therapeutic use of peptides promoting lipid efflux, which could treat hypertriglyceridemia, hypercholesterolemia, and diabetes.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights